Total Payments
$471,292
2024 Payments
$88,831
Companies
17
Transactions
738
Medicare Patients
506
Medicare Billing
$71,955
Payment Breakdown by Category
Other$395,472 (83.9%)
Consulting$40,423 (8.6%)
Travel$23,892 (5.1%)
Food & Beverage$11,271 (2.4%)
Education$234.50 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $366,418 | 271 | 77.7% |
| Consulting Fee | $40,423 | 18 | 8.6% |
| Honoraria | $29,010 | 14 | 6.2% |
| Travel and Lodging | $23,892 | 123 | 5.1% |
| Food and Beverage | $11,271 | 308 | 2.4% |
| Education | $234.50 | 3 | 0.0% |
| Grant | $43.95 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $173,983 | 255 | $0 (2024) |
| Lilly USA, LLC | $129,792 | 240 | $0 (2023) |
| Lundbeck LLC | $38,715 | 43 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $31,464 | 26 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $29,755 | 39 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $28,817 | 33 | $0 (2021) |
| Allergan, Inc. | $20,924 | 33 | $0 (2021) |
| Eli Lilly and Company | $8,515 | 22 | $0 (2023) |
| IMPEL PHARMACEUTICALS INC. | $8,507 | 16 | $0 (2023) |
| PFIZER INC. | $358.37 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $88,831 | 148 | ABBVIE INC. ($76,976) |
| 2023 | $45,148 | 102 | AbbVie Inc. ($20,453) |
| 2022 | $98,096 | 119 | ABBVIE INC. ($43,720) |
| 2021 | $103,783 | 123 | AbbVie Inc. ($32,835) |
| 2020 | $108,192 | 154 | Lilly USA, LLC ($65,130) |
| 2019 | $26,872 | 74 | Lilly USA, LLC ($26,503) |
| 2018 | $284.94 | 16 | Novartis Pharmaceuticals Corporation ($135.01) |
| 2017 | $85.59 | 2 | Avanir Pharmaceuticals, Inc. ($61.54) |
All Payment Transactions
738 individual payment records from CMS Open Payments — Page 2 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $0.11 | General |
| 11/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $1.08 | General |
| Category: PAIN | ||||||
| 10/31/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: PAIN | ||||||
| 10/30/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: NEUROLOGY | ||||||
| 10/25/2024 | Lundbeck LLC | VYEPTI (Biological) | Travel and Lodging | Cash or cash equivalent | $236.17 | General |
| Category: NEUROLOGY | ||||||
| 10/24/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $124.46 | General |
| Category: NEUROLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,675.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $70.78 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Travel and Lodging | In-kind items and services | $65.66 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Lundbeck LLC | VYEPTI (Biological) | Travel and Lodging | Cash or cash equivalent | $40.00 | General |
| Category: NEUROLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Travel and Lodging | In-kind items and services | $25.30 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $9.62 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.96 | General |
| Category: NEUROSCIENCE | ||||||
| 10/06/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $42.19 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $64.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $33.50 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $532.96 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $205.81 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $158.74 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $74.00 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 78 | 123 | $49,597 | $12,306 |
| 2022 | 4 | 100 | 154 | $54,396 | $15,974 |
| 2021 | 8 | 165 | 298 | $157,373 | $25,375 |
| 2020 | 8 | 163 | 274 | $79,082 | $18,301 |
Total Patients
506
Total Services
849
Medicare Billing
$71,955
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 22 | 66 | $25,674 | $6,229 | 24.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 21 | $8,925 | $2,209 | 24.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $8,596 | $2,156 | 25.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 22 | $6,402 | $1,712 | 26.7% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 25 | 74 | $28,786 | $7,064 | 24.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 40 | $9,552 | $3,348 | 35.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 19 | 19 | $9,167 | $2,871 | 31.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 18 | 21 | $6,891 | $2,690 | 39.0% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2021 | 18 | 55 | $21,395 | $5,724 | 26.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 26 | 26 | $12,142 | $4,265 | 35.1% |
| 64450 | Injection of anesthetic agent and/or steroid into other peripheral nerve or branch | Office | 2021 | 16 | 51 | $53,835 | $4,186 | 7.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 39 | 47 | $10,951 | $3,841 | 35.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 18 | 22 | $6,864 | $2,692 | 39.2% |
| 64405 | Injection of anesthetic agent and/or steroid into greater occipital nerve of upper neck and back of head | Office | 2021 | 16 | 49 | $37,525 | $2,044 | 5.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 19 | 19 | $6,802 | $2,031 | 29.9% |
| 20552 | Injections of trigger points in 1 or 2 muscles | Office | 2021 | 13 | 29 | $7,859 | $591.36 | 7.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 37 | 53 | $12,349 | $4,103 | 33.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 28 | 28 | $12,068 | $4,077 | 33.8% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2020 | 14 | 32 | $12,448 | $3,113 | 25.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 27 | 30 | $9,360 | $3,061 | 32.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 19 | 19 | $6,802 | $2,168 | 31.9% |
| 64450 | Injection of anesthetic agent and/or steroid into other peripheral nerve or branch | Office | 2020 | 12 | 16 | $14,430 | $1,098 | 7.6% |
| 64405 | Injection of anesthetic agent and/or steroid into greater occipital nerve of upper neck and back of head | Office | 2020 | 13 | 16 | $10,665 | $592.60 | 5.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2020 | 13 | 80 | $960.00 | $88.50 | 9.2% |
About Dr. Megan Donnelly, D.O
Dr. Megan Donnelly, D.O is a Neurology healthcare provider based in Charlotte, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2011. The National Provider Identifier (NPI) number assigned to this provider is 1437444346.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Megan Donnelly, D.O has received a total of $471,292 in payments from pharmaceutical and medical device companies, with $88,831 received in 2024. These payments were reported across 738 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($366,418).
As a Medicare-enrolled provider, Donnelly has provided services to 506 Medicare beneficiaries, totaling 849 services with total Medicare billing of $71,955. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Charlotte, NC
- Active Since 06/20/2011
- Last Updated 10/26/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1437444346
Products in Payments
- UBRELVY (Drug) $96,425
- EMGALITY (Drug) $68,705
- NURTEC ODT (Drug) $58,721
- QULIPTA (Drug) $55,072
- REYVOW (Drug) $48,600
- VYEPTI (Biological) $38,715
- BOTOX (Biological) $35,333
- AJOVY (Biological) $31,165
- Trudhesa (Drug) $8,507
- AJOVY (Drug) $298.31
- ZAVZPRET (Drug) $149.40
- GILENYA (Drug) $121.62
- ZIO Patch (Device) $60.50
- AIMOVIG (Biological) $41.27
- COMIRNATY (Biological) $33.21
- PAXLOVID (Drug) $26.32
- Briviact (Drug) $24.05
- ZIO XT Patch (Device) $20.00
- TECFIDERA (Drug) $14.09
- Betaseron (Drug) $13.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Charlotte
Jill Conway, Md, MD
Neurology — Payments: $1.5M
Neurology $1.5M
Sanjay Iyer, Md, MD
Neurology — Payments: $620,868
Neurology $620,868
Danielle Englert Doggett, Md, MD
Neurology — Payments: $224,230
Neurology $224,230
Ardith Courtney, Do, DO
Neurology — Payments: $215,565
Neurology $215,565
Mohammad Bolouri, Md, MD
Neurology — Payments: $184,450
Neurology $184,450
Joseph Chipman, Md, MD
Neurology — Payments: $120,418
Neurology $120,418